Mikko A I Keränen (Mikko Keränen)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Replacement Therapy

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Science advances

Hematology reports

This page only lists publications with an associated author ORCID identifier.

Publications

David Michonneau, Raynier Devillier, Mikko A I Keränen, Marie Thérèse Rubio, Malin Nicklasson, Hélène Labussière-Wallet, Martin Carre, Anne Huynh, Elisabet Viayna, Montserrat Roset, Jonathan Finzi, Minja Pfeiffer, Daniel Thunström, Núria Lara, Lorenzo Sabatelli, Patrice Chevallier, Maija Itälä-Remes
Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study. Hematology reports 16 (2) (2024)
David Michonneau, Raynier Devillier, Mikko A I Keränen, Marie Thérèse Rubio, Malin Nicklasson, Hélène Labussière-Wallet, Martin Carre, Anne Huynh, Elisabet Viayna, Montserrat Roset, Jonathan Finzi, Minja Pfeiffer, Daniel Thunström, Núria Lara, Lorenzo Sabatelli, Patrice Chevallier, Maija Itälä-Remes
Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study. Hematology reports 16 (2) (2024)
Sofie A Lundgren, Mikko Myllymäki, Timo Järvinen, Mikko A I Keränen, Jason Theodoropoulos, Johannes Smolander, Daehong Kim, Urpu Salmenniemi, Gunilla Walldin, Paula Savola, Tiina Kelkka, Hanna L M Rajala, Eva Hellström Lindberg, Maija Itälä-Remes, Matti Kankainen, Mohamed El Missiry
Somatic mutations associate with clonal expansion of CD8 + T cells. Science advances 10 (23) (2024)
Sofie A Lundgren, Mikko Myllymäki, Timo Järvinen, Mikko A I Keränen, Jason Theodoropoulos, Johannes Smolander, Daehong Kim, Urpu Salmenniemi, Gunilla Walldin, Paula Savola, Tiina Kelkka, Hanna L M Rajala, Eva Hellström Lindberg, Maija Itälä-Remes, Matti Kankainen, Mohamed El Missiry
Somatic mutations associate with clonal expansion of CD8 + T cells. Science advances 10 (23) (2024)